The effect of genetic polymorphism on the dose and tlerability to beta-blocker therapy in turkish heart failure population

dc.contributor.authorZoghi, M. Mehdi
dc.contributor.authorYilmaz, M. B.
dc.contributor.authorCavusoglu, Y.
dc.contributor.authorAykut, A.
dc.contributor.authorOnay, H.
dc.contributor.authorErgene, O.
dc.date.accessioned2019-10-27T22:26:59Z
dc.date.available2019-10-27T22:26:59Z
dc.date.issued2015
dc.departmentEge Üniversitesien_US
dc.identifier.endpage91en_US
dc.identifier.issn1388-9842
dc.identifier.issn1879-0844
dc.identifier.startpage91en_US
dc.identifier.urihttps://hdl.handle.net/11454/50528
dc.identifier.volume17en_US
dc.identifier.wosWOS:000366200401287en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofEuropean Journal of Heart Failureen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe effect of genetic polymorphism on the dose and tlerability to beta-blocker therapy in turkish heart failure populationen_US
dc.typeConference Objecten_US

Dosyalar